Interim Results From A Phase I/II Study Of Hpn328, A Tri-Specific, Half-Life (T1/2) Extended Dll3-Targeting T Cell Engager In Patients (Pts) With Small Cell Lung Cancer (Sclc) And Other Neuroendocrine Neoplasms (Nen)
HPN-328
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Interim Results From A Phase I/II Study Of Hpn328, A Tri-Specific, Half-Life (T1/2) Extended Dll3-Targeting T Cell Engager In Patients (Pts) With Small Cell Lung Cancer (Sclc) And Other Neuroendocrine Neoplasms (Nen) ### Output: HPN-328